Jump to navigation
Jump to content
Site navigation
About
Our Story
Our History
What's at BioQuarter
Our Partners
BioLife
What's Happening
Companies
Sustainable Travel
Community
Community Engagement
Community Programmes
STEM Education
Get Involved
Locate Here
Locate Here
Property Offering
Contact Us
Contact Us
Getting here
Log in
News Archive
Case Studies
Events
News
23 May 2019
LifeArc monetises Keytruda® (pembrolizumab) royalty interests to fund further research and investment
Contact
Us
